Page last updated: 2024-10-26

disulfiram and Carcinoma, Renal Cell

disulfiram has been researched along with Carcinoma, Renal Cell in 2 studies

Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Ni, X1
Ye, C1
Yu, X1
Zhang, Y1
Hou, Y1
Zheng, Q1
Chen, Z1
Wang, L1
Weng, X1
Yang, C1
Liu, X1
Yoshino, H1
Yamada, Y1
Enokida, H1
Osako, Y1
Tsuruda, M1
Kuroshima, K1
Sakaguchi, T1
Sugita, S1
Tatarano, S1
Nakagawa, M1

Other Studies

2 other studies available for disulfiram and Carcinoma, Renal Cell

ArticleYear
Overcoming the compensatory increase in NRF2 induced by NPL4 inhibition enhances disulfiram/copper-induced oxidative stress and ferroptosis in renal cell carcinoma.
    European journal of pharmacology, 2023, Dec-05, Volume: 960

    Topics: Animals; Carcinoma, Renal Cell; Copper; Disulfiram; Ferroptosis; Kidney Neoplasms; Mice; NF-E2-Relat

2023
Targeting NPL4 via drug repositioning using disulfiram for the treatment of clear cell renal cell carcinoma.
    PloS one, 2020, Volume: 15, Issue:7

    Topics: Acetaldehyde Dehydrogenase Inhibitors; Animals; Apoptosis; Biomarkers, Tumor; Carcinoma, Renal Cell;

2020